INTRODUCTION {#sec1-1}
============

Chloramphenicol is a broad spectrum antibiotic that gained popularity in the late 1940s for ophthalmic and systemic infections including upper respiratory infections, acne, and bronchitis.\[[@ref1]\] Beginning in the 1950s, landmark case reports demonstrated a possible relationship between chloramphenicol and aplastic anemia, bone marrow suppression, and blood dyscrasias;\[[@ref2][@ref3]\] which lead to a drop in use by as much as 80% in the United States.\[[@ref4]\] Comparing data in the United Kingdom during the 1990\'s, incidence of topical chloramphenicol was shown to have a low incidence of adverse events, while maintaining good efficacy against most pathogens at a low cost,\[[@ref1][@ref5][@ref6]\] making it a preferred first-line antibiotic among some ophthalmologist and otolaryngologists. Additionally, in the United States, case reports are surfacing showing chloramphenicol use for otitis media,\[[@ref7]\] meningitis,\[[@ref8]\] brain abscess treatment,\[[@ref1]\] and multiple accounts of vancomycin resistant infections.\[[@ref9]\] As such, emergency physicians are again considering chloramphenicol adverse effects as a differential diagnoses in some of the patient populations.

Although Candida esophagitis was diagnosed in a child taking multiple antibiotics in 1989,\[[@ref10]\] association of acute, nonfungal, esophagitis after initial use of topical chloramphenicol has not been reported. We report a case of a woman who presented to the emergency department with chest pain 2 weeks after initiating topical chloramphenicol applied to an ear canal that was status post tympanoplasty.

CASE REPORT {#sec1-2}
===========

A 31-year-old Caucasian, military dependent, female presented to the Naval Medical Center Emergency Department with a chief complaint of "chest discomfort", further described as a "burning sensation that started in (her) throat and migrated down to (her) chest". This symptom occurred once before, 3 days prior to this presentation. She denied radiation of symptoms, dyspnea, or any other associated symptoms. She had not experienced these symptoms in the past. Her past medical history was significant for being 4 months status post, uncomplicated, right tympanoplasty as treatment for a middle ear cholesteatoma, irritable bowel syndrome, and adenoid cyst carcinoma 5 years past. Review of her current, active medications includes a chloramphenicol, sulfanilamide, fungizone, and hydrocortisone otic insufflation combination (CSF + HC) for an otitis of her right ear. The medication was started approximately 2 weeks prior to her presentation. She noted burn-like throat pain that migrated down to her chest occurring twice after starting this treatment. Review of her social and family history revealed no risk factors for cardiopulmonary disease and was otherwise noncontributory. She was a nonsmoker and marginal alcohol consumer.

On physical exam, the patient was comfortable, pleasant, in no acute distress and breathing with normal oxygen saturation at a regular rate. Her vitals were within normal limits and stable. Heart, lungs, and vascular exam were normal. On head, ears, eyes, nose, and throat (HEENT) examination; the right tympanic membrane appeared to have postsurgical changes with a noted defect; otherwise the ear canal was clean without discharge or erythema. Oropharyngeal exam was unremarkable. The remainder of her exam was unremarkable. An electrocardiogram (ECG) was obtained which demonstrated a normal sinus rhythm. Her symptoms resolved completely after consuming a gastrointestinal cocktail. She was monitored for 2 h with no change in status and continued resolution of symptoms. She was discharged with an H2 blocker and referred to her otolaryngologist for evaluation.

DISCUSSION {#sec1-3}
==========

Discovered in 1947 as a product of *Streptomyces venezuelae*,\[[@ref1]\] chloramphenicol acts by inhibiting protein synthesis via the 50S ribosomal subunit.\[[@ref1]\] It is largely bacteriostatic, but also shows bactericidal activity against common pathogens of eyes, ears, nose, and throat infections as well as meningeal pathogens, namely *Hemophilus influenzae*, *Streptococcus pneumoniae*, and *N. meningitidis*.\[[@ref1]\] Shortly after chloramphenicol\'s discovery, it rapidly gained popularity owing to its broad spectrum coverage, good tissue penetration, and low cost. In the 1950s; however, two landmark case reports presented a possible correlation of a lethal blood dyscrasias and bone marrow suppression due to topical and systemic chloramphenicol\[[@ref2][@ref3]\] with an incidence believed to be in the order of one in 24,000-40,000.\[[@ref1][@ref6]\] Two mechanisms of such an adverse effect originally included dose-dependent and reversible bone marrow suppression secondary to mitochondrial protein synthesis inhibition, as well as an idiosyncratic reaction resulting from deoxyribonucleic acid (DNA) damage.\[[@ref1]\]

This conclusion has been called into question. Case reports and editorials have surfaced in the past 2 decades that argue in favor of chloramphenicol\'s low resistant patterns, low cost, and high efficacy as a topical\[[@ref6]\] and systemic antibiotic.\[[@ref1]\] Correlation between eye drops and bone marrow suppression seemed to be weaker than originally thought.\[[@ref5]\] Lancaster and colleagues retrospectively reviewed medical charts and found an incidence of aplastic anemia amongst patients on chloramphenicol eye drops to be three per 442,543 over 7 years, enhancing the argument that chloramphenicol-induced aplastic anemia is exceedingly rare.\[[@ref5]\]

Dr. Sherwin Isenberg pointed out that outside of North America chloramphenicol is one of the more popular first-line antibiotics.\[[@ref11]\] In the US, the use is comparatively less common. However, individual US case reports have surfaced as well as mutlicenter studies looking at antibiotic use showing chloramphenicol is still a medication prescribed within the US. Additionally, the US Food and Drug Administration points out the growing issue of medications smuggled from Mexico and Canada for personal use as well as for retail.\[[@ref12]\] Given the popularity of this medication internationally, it is important to have a growing knowledge of chloramphenicol\'s side effects for potential presentations in US emergency departments.

Such side effects include ototoxicity,\[[@ref13]\] metabolic acidosis, encephalopathy, and neurotoxicity.\[[@ref1]\] Thapa and Kumar reported two pediatric cases of *Candida* esophagitis in 2- and 9-year-old boys.\[[@ref10]\] Both of which were on an oral chloramphenicol dose for *Salmonella* and fever, respectively. These cases demonstrate an association of esophagitis with symptoms of pain and dysphagia with an oral chloramphenicol. Outside of Candida esophagitis, there appears to be no other reported association to date of esophageal irritation/injury secondary to chloramphenicol. However, contact dermatitis with symptoms of erythema, edema, pruritus, and hyperemia of the face as well as arms have been seen with topical chloramphenicol.\[[@ref14]\] Furthermore, Collins *et al*., described 16 cases of drug associated esophageal injury, seven of which were antibiotics including doxycycline and clindamycin.\[[@ref15]\]

Ototopic chloramphenicol in patients with tympanic membrane perforation show a low, but increased risk of ototoxity compared to nonperforated membrane\[[@ref13]\] arguably due to loss of a barrier. In the case presented, the patient used an otic insufflation for her right ear after a recent tympanoplasty, likely allowing ototopical chloramphenicol to come in contact with the esophagus leading to symptoms reported upon presentation. Limitations of the described case report include the lack of supporting evidence for the proposed mechanism in the literature as well as clinical diagnostic studies at the time of evaluation. However, this case presents an interesting presentation of a patient taking a medication not commonly seen in the US. This patient had no prior history of gastroesophageal reflux disease, and this patient\'s symptom began within days of starting the chloramphenicol. It is reasonable to consider chloramphenicol in the differential as a causative agent for this presentation after ruling out other urgent etiology.

CONCLUSION {#sec1-4}
==========

Chloramphenicol has gained popularity for its efficacy, low resistance, and very low cost. Its use was markedly reduced in the developed world due to presumed lethal bone marrow suppression and aplastic anemia. New insight has shown association of aplastic anemia and bone marrow suppression with topical chloramphenicol to be far less common than originally thought. However, other adverse effects of this medication should be highlighted given the upward trend of its use in the US. This case report presents a 31-year-old female with very limited risk factors for cardiopulmonary or vascular disease who presented with chest discomfort. Detailed history revealed she was approximately 4 months status post tympanoplasty and currently on chloramphenicol otic insufflator. Given documented evidence of antibiotic induced esophageal injury and esophagitis, and the loss of a barrier preventing an otherwise ototopical agent from being ingested, the patient was treated for presumed chloramphenicol-induced esophagitis.
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